A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

Clinical trial NCT07038200 · RECRUITING

Trial details

NCT number: NCT07038200
Sponsor: Avidity Biosciences, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Facioscapulohumeral Muscular Dystrophy FSHD FSHD - Facioscapulohumeral Muscular Dystrophy FSHD1 FSHD2 Fascioscapulohumeral Muscular Dystrophy Fascioscapulohumeral Muscular Dystrophy Type 1 Fascioscapulohumeral Muscular Dystrophy Type 2 Facioscapulohumeral Muscular Dystrophy 1 Facioscapulohumeral Dystrophy Facio-Scapulo-Humeral Dystrophy Facioscapulohumeral Muscular Dystrophy 2

Start date: 2025-06-10
Primary completion: 2028-05-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.